Jens Ole Laursen1. 1. Department of Orthopedic Surgery and Emergency Department, County Hospital of South Jutland, Vimmelskaftet 16, 6470, Sydals, Denmark. jens.ole.laursen@rsyd.dk.
Abstract
PURPOSE: The HemiCAP-Wave® implant for the patellofemoral resurfacing treatment of large cartilage lesions and osteoarthritis (OA) was introduced in 2009. The outcome of a prospective cohort study of 18 patients with large trochlea lesions or isolated OA treated with the HemiCAP-Wave® implant is presented with up to a 6-year survival rate, and hypothesised short-to mid-term reduced pain and improved function. METHODS: Indication for treatment with the HemiCAP-Wave® implant was a symptomatic, large cartilage lesion in trochlea demonstrated by MRI or arthroscopy, which was ICRS grades 3-4 and larger than 4 cm2. Patients were followed for 2 years with American Knee Society Subjective outcome Scores (AKSS), pain scores and radiographic evaluations and for up to 6 years with complications and reoperations. RESULTS: At the 1- and 2-year follow-up mean AKSS clinical score, the mean AKSS function score and mean pain score improved significantly. Within 6 years, 28 % of the implants were revised to arthroplasty due to the progression of cartilage lesions, osteoarthritis or increased knee pain. CONCLUSION: The present study demonstrated an improved short- to mid-term clinical outcome and reduced pain but high mid-term revision rate after patellofemoral inlay resurfacing using the HemiCAP-Wave® implant. Patellofemoral resurfacing implantation treatment with a large inlay prosthesis can offer temporary treatment for large isolated patellofemoral cartilage lesions or OA in younger patients with almost healthy cartilage in the other compartments who are not yet eligible for arthroplasty treatment. LEVEL OF EVIDENCE: IV.
PURPOSE: The HemiCAP-Wave® implant for the patellofemoral resurfacing treatment of large cartilage lesions and osteoarthritis (OA) was introduced in 2009. The outcome of a prospective cohort study of 18 patients with large trochlea lesions or isolated OA treated with the HemiCAP-Wave® implant is presented with up to a 6-year survival rate, and hypothesised short-to mid-term reduced pain and improved function. METHODS: Indication for treatment with the HemiCAP-Wave® implant was a symptomatic, large cartilage lesion in trochlea demonstrated by MRI or arthroscopy, which was ICRS grades 3-4 and larger than 4 cm2. Patients were followed for 2 years with American Knee Society Subjective outcome Scores (AKSS), pain scores and radiographic evaluations and for up to 6 years with complications and reoperations. RESULTS: At the 1- and 2-year follow-up mean AKSS clinical score, the mean AKSS function score and mean pain score improved significantly. Within 6 years, 28 % of the implants were revised to arthroplasty due to the progression of cartilage lesions, osteoarthritis or increased knee pain. CONCLUSION: The present study demonstrated an improved short- to mid-term clinical outcome and reduced pain but high mid-term revision rate after patellofemoral inlay resurfacing using the HemiCAP-Wave® implant. Patellofemoral resurfacing implantation treatment with a large inlay prosthesis can offer temporary treatment for large isolated patellofemoral cartilage lesions or OA in younger patients with almost healthy cartilage in the other compartments who are not yet eligible for arthroplasty treatment. LEVEL OF EVIDENCE: IV.
Authors: P C Kreuz; M R Steinwachs; C Erggelet; S J Krause; G Konrad; M Uhl; N Südkamp Journal: Osteoarthritis Cartilage Date: 2006-07-11 Impact factor: 6.576
Authors: Kai Mithoefer; Riley J Williams; Russell F Warren; Hollis G Potter; Christopher R Spock; Edward C Jones; Thomas L Wickiewicz; Robert G Marx Journal: J Bone Joint Surg Am Date: 2005-09 Impact factor: 5.284
Authors: Matthias J Feucht; Patricia M Lutz; Conrad Ketzer; Marco C Rupp; Matthias Cotic; Andreas B Imhoff; Jonas Pogorzelski Journal: Arch Orthop Trauma Surg Date: 2020-10-30 Impact factor: 3.067
Authors: Andreas B Imhoff; Eva Bartsch; Christoph Becher; Peter Behrens; Gerrit Bode; Matthias Cotic; Theresa Diermeier; Holger Falk; Matthias J Feucht; Ulrich Haupt; Stefan Hinterwimmer; Johannes Holz; René Hutter; René Kaiser; Tobias Knoblauch; Wolfgang Nebelung; Philipp Niemeyer; Turlough O'Donnel; Geert Pagenstert; Thilo Patzer; Tim Rose; Marco C Rupp; Thomas Tischer; Arne J Venjakob; Stephan Vogt; Jonas Pogorzelski Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-04-02 Impact factor: 4.342